February 18, 2026 | HearFromHer, RareDisease
In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical system often defaults to “normalizing” debilitating symptoms.

Listen to the full episode here.
In the latest episode of the Hear From Her podcast, Tatyana Kushner (Weill Cornell Medicine) and Andrea Goldstein (Mirum Pharmaceuticals), discuss why this status quo is dangerous. While ICP might present as “just an itch,” it is a complex condition where elevated bile acids can lead to severe risks for the infant, including respiratory distress or stillbirth.
The Data Behind the Disparities Recent research led by Dr. Kushner suggests a 70% recurrence rate for ICP in subsequent pregnancies. Furthermore, the data reveals significant racial disparities; for instance, while Primary Biliary Cholangitis (PBC) was long thought to be a condition primarily affecting Northern European women, it is now clear that women of color face significant barriers to diagnosis and access to care.
Listen to the full episode here.
The Future of Care: Genetics and Advocacy
As Andrea Goldstein puts it, “Every failure in a study leads to key learnings that help us be successful the next time.” For the modern clinician and patient alike, the goal is clear: don’t just learn the system—have the courage to change it. Listen to the full episode here.
Follow us for updates on upcoming podcasts and more insightful conversations.
For more information, please contact Jelena Spyropoulos.
About Medscape Education
Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professional
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Tomorrow at 2 PM ET, join Medscape for a thought-provoking Afternoon Snack Session at CMEpalooza Spring 2025, titled “Reverse Planning with Forward Thinking.” This session will spotlight how clear communication…
As deadly as the measles outbreak in west Texas and New Mexico is the spread of vaccine conspiracy theories and misinformation. According to KFF research from November 2024, childhood vaccination…
How do we impress upon women that they need to prioritize their own health before providing for the people who need them? A leader in medical oncology has a few…
Medscape, a global leader in infectious disease education, continues its commitment to advancing knowledge in the field. With 1.47 million ID learners in 2024, the Medscape team will travel to…
Artificial intelligence (AI) is revolutionising the field of cardiology, offering new hope for patients with cardiovascular disorders. AI is no longer futuristic, it’s a real-world tool, transforming patient care and…
The Medscape team is back in Chicago for the much-anticipated ACC 2025 conference, March 29-31, bringing an array of engaging educational booth highlights, interactive symposia, scientific posters, and more for…
Medscape is proud to highlight Michelle A. Worst, PharmD, BCOP, MBA, CHCP, Senior Director and Team Lead of Clinical Strategy in Hematology/Oncology, for her well-deserved recognition as the recipient of…
Medscape Education, the leader in continuing medical education for healthcare professionals, is extending its commitment to closing gaps in women’s health by expanding the efforts of its Innovations in Women’s…
One of the toughest challenges of educating many African women about female cancers and disease prevention is overcoming cultural biases, as well as shame, stigma, and misinformation. Here’s how two…
Just in time for Women’s History Month and International Women’s Day on March 8th, Medscape is proud to showcase its dedication to advancing women’s health education. Sara Thorpe, MPH, Director,…
